BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,921,076 | +243.4% | 595,800 | +245.4% | 0.09% | +135.1% |
| Q2 2022 | $8,712,000 | -79.7% | 172,482 | -58.8% | 0.04% | -80.4% |
| Q3 2021 | $42,995,000 | +87.4% | 418,200 | +60.3% | 0.19% | +83.5% |
| Q2 2021 | $22,944,000 | +36.6% | 260,844 | +24.4% | 0.10% | +17.0% |
| Q4 2019 | $16,801,000 | -34.6% | 209,729 | -25.1% | 0.09% | -17.8% |
| Q1 2018 | $25,672,000 | +14.2% | 279,957 | -6.1% | 0.11% | +10.3% |
| Q4 2017 | $22,473,000 | +2.0% | 298,009 | -5.8% | 0.10% | -1.0% |
| Q3 2017 | $22,030,000 | +9.2% | 316,200 | -20.6% | 0.10% | -13.3% |
| Q2 2017 | $20,172,000 | +389.7% | 398,108 | +286.5% | 0.11% | +391.3% |
| Q1 2017 | $4,119,000 | – | 103,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |